Xihu Innovation Investment
西湖创新投资
Xihu Innovation Investment (西湖创新投资) appears in elsewhere's corpus only through its deal activity in early 2022, not through a dedicated profile. It led KSKD's (凯思凯迪) roughly 100-million-yuan Pre-A+ round in February 2022, with existing shareholders Gaorong Capital, Fuhui Ventures and Jindi Capital following on , and around the same period it was among the backers of Aikai Biotech, a startup that closed three funding rounds within its first year alongside Lianxin Capital, 5Y Capital and others . Both deals are in biopharma/life sciences, but elsewhere's corpus does not cover the fund's own background — its founding, size, or affiliation — beyond these investments.
AI-generated — may contain errors, please verify.
Coverage
April: Imagination Is the Courage with Which We Face the World | 5Y News Monthly
The big news from last month.
5Y News | Aikai Biotech Completes Three Funding Rounds in Its First Year
Innovate from the source.
Global SaaS, New Brands, and Biopharma Companies Close New Funding Rounds | Rongbao · February
The vitality of spring.
Dialogue with CASI's Huaqiang Xu: "Following Nature's Way" in Drug R&D | Gaorong "Future"
CasKedy announced the completion of a nearly RMB 100 million Pre-A+ funding round.
